Abstract: The present disclosure is directed to a polycell for forming a dosage projectile suitable for administering a biologically active agent to an animal remotely, the polycell comprising a first component having a semispherical shell formed from a polymer and a structural agent; a second component having a semispherical shell formed from a polymer and a structural agent; and a filling port in the first component or the second component; wherein the first and second components when joined form a polycell having a substantially spherical hollow body adapted to receive an agent to treat an animal. The present disclosure is also directed to a dosage projectile comprising an agent to treat an animal sealed in a polycell.

Abstract: A remote treatment delivery system for an animal including a dosage projectile adapted to deliver a biologically active agent to an animal substantially without piercing the skin of the animal and containing a biologically active agent and a carrier in liquid or gel form, the carrier allows adhesion of the biologically active agent to skin, coat or fur of the animal; wherein the agent and the carrier are encapsulated in one or more encapsulating agents; and wherein the encapsulating agents forms a frangible shell.

Abstract: A remote treatment delivery system for an animal including a dosage projectile adapted to deliver a biologically active agent to an animal substantially without piercing the skin of the animal and containing a biologically active agent and a carrier in liquid or gel form, the carrier allows adhesion of the biologically active agent to skin, coat or fur of the animal; wherein the agent and the carrier are encapsulated in one or more encapsulating agents; and wherein the encapsulating agents forms a frangible shell.

Abstract: A method of remotely treating an animal including launching a delivery system at the animal, wherein the delivery system comprises a dosage projectile adapted to deliver a biologically active agent to an animal substantially without piercing the skin of the animal and containing a biologically active agent and a transdermal carrier in liquid or gel form, wherein the agent and the carrier are encapsulated in one or more encapsulating agents, and wherein the encapsulating agents forms a frangible shell; impacting the projectile on the animal to release the biologically active agent and the transdermal carrier from the frangible shell substantially without piercing the skin of the animal; and delivering the biologically active agent to the animal, wherein the transdermal carrier facilitates passage of the biologically active agent across the skin of the animal to provide treatment to the animal.

Abstract: A remote treatment delivery system comprising a substantially non-skin piercing dosage projectile containing a biologically active agent and a transdermal carrier.

Abstract: A remote treatment delivery system comprising a substantially non-skin piercing dosage projectile containing a biologically active agent and a transdermal carrier.